Evolution of the Average Target: GSK plc

Evolution of the Target Price: GSK plc

Changes in Analyst Recommendations: GSK plc

f144c364bdb330fbc0f.kqrg7d-N8mqVPYpFTY-Ela4VXEJ1QLwKuBeRTHxmNO0.8cWYrpr7owvdeOwaferL_dZ3LDskENhv_XGofxFSApWi46mFu_2mGPli_Q~dcebbe62660f5d8ef5000a74a248f89e

Add to a list
Analyst Opinion 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+22.27%
+9.85%
+7.10%
+2.55%
+1.47%
+17.53%
+13.11%
+16.47%
+0.67%
-2.43%
Average +8.86%
Weighted average by Cap. +8.12%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
16.10GBP
Average target price
19.22GBP
Spread / Average Target
+19.41%
High Price Target
34.79GBP
Spread / Highest target
+116.14%
Low Price Target
14.20GBP
Spread / Lowest Target
-11.77%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

JEFFERIES Peter Welford
JPMORGAN James Gordon
alphavalue Abhishek Raval
GOLDMAN SACHS Rajan Sharma
DEUTSCHE BANK RESEARCH Emmanuel Papadakis
BERENBERG Kerry Holford
UBS Jo Walton
DZ BANK Elmar Kraus
Citigroup
AlphaValue/Baader Europe
HSBC
LBBW
Jefferies & Co.
Bernstein
BERNSTEIN RESEARCH Justin Smith
Barclays
Guggenheim
Deutsche Bank Securities
Morgan Stanley
Berenberg Bank
CREDIT SUISSE Dominic Lunn
Bank of America Securities/Merrill Lynch
Stifel Nicolaus
ODDO BHF
Societe Generale
Liberum Capital
J.P. Morgan Chase
DEUTSCHE BANK Emmanuel Papadakis
KEPLER CHEUVREUX David Evans
BAADER BANK
SVB Leerink
BANK OF AMERICA (BOFA) Graham Parry
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities. Last hours!
BENEFIT NOW